US Patent 12104188 Modified caspase-9 polypeptides and methods of use thereof
Patent 12104188 was granted and assigned to Allogene Therapeutics on October, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 8, 2022
0
Date of Patent
October 1, 2024
0
Patent Applicant
Patent Application Number
17716253
0
Patent Citations
Patent Inventor Names
Thomas John Van Blarcom
0
Meritxell Galindo Casas
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 12104188 Modified caspase-9 polypeptides and methods of use thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
